Similac baby formula maker Abbott is expected to face a trial on Monday over claims that its formula for preterm infants used in neonatal intensive care units causes a potentially deadly bowel disease ...
Previous studies in preterm infants have shown that probiotic supplementation has enhanced mucosal barrier function and limited growth of gastrointestinal bacteria. 5 However, data on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results